About this trial
The aim of this study is to describe national trends over the past 10 years in patients receiving invasive home mechanical ventilation (HMV) in Denmark. This includes indications for invasive HMV, diagnostic groups, and one-year mortality.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients are included if they have or have had a respiratory certified personale care assistent during the period 2016-2025.
Disqualifiers
Not tracheostomized
Tracheostomized but on spontaneous breathing throughout 1 January 2016 - 31 December 2025
Not discharged to home, assisted living, nursing home, or rehabilitation during 1 January 2016 - 31 December 2025
Trial population
Patients in Denmark with a respiratory certified personale care assistent who are fully or partially dependent on invasive ventilation during the period 2016-2025.
Trial design
Case-only
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence of patients with invasive home mechanical ventilation
Incidence of patients with invasive home mechanical ventilation per year per 100,000 population
Secondary outcomes
Prevalence of patients on home mechanical ventilation pr. year
Number of new patients on invasive home mechanical ventilation per year
The absolute number of patients starting on invasive home mechanical ventilation each year.
One-year mortality
1-year mortality after initiation of invasive home mechanical ventilation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Rigshospitalet, Denmark
Lead sponsor
Aarhus University Hospital
Collaborator
Odense University Hospital
Collaborator